Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solitary chemosensory cells in the nasal mucosa are specialized epithelial cells that function as sentinels in the airways, detecting potentially toxic or irritating substances in the inhaled air[1]. These cells express taste receptor molecules (notably T2R “bitter taste” receptors) and the G protein α-gustducin, similar to taste receptor cells in the tongue and related chemosensory cells of the gut[1]. When activated by irritants or bitter compounds, these cells form synaptic contacts with trigeminal nerve fibers and trigger protective respiratory reflexes such as sneezing or temporary apnea, thus preventing harmful substances from entering deeper into the airway or lungs[1]. Unlike classical drug targets (receptors, enzymes, etc.), these cells do not represent a single molecular target but rather a cell population with chemosensory function in the nasal epithelium. Their relevance for therapeutic manipulation in human disease is limited and not established; they are not (as of current scientific consensus) considered classical therapeutic targets. **Key clarification:** - “Chemoreceptors in nasal mucosa” is not a canonical, druggable target but rather refers to a class of chemosensory cells (e.g., solitary chemosensory cells, not a uniquely identified receptor)[1]. - There is no current therapeutic targeting, clinical biomarker, or established drug mechanism specifically involving these cells[1][2]. - If you require information about a well-defined receptor type in the nasal mucosa (e.g., TRPA1, specific olfactory or taste receptors), please give a more precise target name. **Summary note:** This entity is not a well-defined molecular target suitable for drug development or structured target databases—it is a heterogeneous cell population with chemosensory and protective functions in upper airway physiology[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solitary chemosensory cell in nasal mucosa (SCC (occasionally used in literature)).